SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...

For patients with bladder cancer undergoing radical cystectomy, or the surgical removal of the bladder, one possible option ...

A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life ...

Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful ...

Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr.

Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood ...

As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or ...

As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and ...

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic ...

Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like ...